WGS

GeneDx Holdings Corp. Class A · NASDAQ

Sector Health Services
Industry Medical/Nursing Services
Website genedx.com
Employees(FY) -
ISIN US81663L2007

Performance

-9.87%

-2.21%

+103.55%

+165.42%

+2509.82%

YTD

+3887.22%

Profile

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.

Advanced Technical Analysis

Technical Analysis of WGS 2024-12-12

The stock indicators reflect a predominantly neutral sentiment, with the Moving Average Score at 50 indicating a balanced trend, while the Oscillators Score of 36 suggests bearish momentum, and the Technical Score of 43 reinforces the overall neutral outlook. This combination implies caution, as the market lacks strong bullish signals despite th...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of WGS

Stock Rank

Recent News & Updates

2024-12-10 05:47
GeneDx Holdings Corp. (NASDAQ:WGS): Is Breakeven Near?(Simply Wall St.)
2024-12-05 08:30
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners(Business Wire)
2024-12-04 19:30
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners(Businesswire)
2024-11-25 13:26
This Once Ultracheap Biotech Stock Rockets 2,762%, Nears Buy Point After Big Earnings Win(Investor's Business Daily)
2024-11-22 16:05
GeneDx to Participate in Upcoming Investor Conference(Business Wire)
2024-11-22 03:05
GeneDx to Participate in Upcoming Investor Conference(Businesswire)
2024-11-20 06:11
Daily – Vickers Top Buyers & Sellers for 11/20/2024(Argus Research)
2024-11-19 08:30
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover(Business Wire)
2024-11-18 19:30
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover(Businesswire)
2024-11-18 08:30
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary(Business Wire)
2024-11-17 19:30
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary(Businesswire)
2024-11-07 16:35
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields(Business Wire)
2024-11-07 03:35
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields(Businesswire)
2024-11-04 16:35
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting(Business Wire)
2024-11-04 03:35
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting(Businesswire)
2024-10-30 08:50
GeneDx Holdings Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
2024-10-29 08:00
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights(Business Wire)
2024-10-28 20:00
GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights(Businesswire)
2024-10-24 11:10
Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening(Business Wire)
2024-10-23 23:10
Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening(Businesswire)
2024-10-08 08:30
GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns(Business Wire)
2024-10-07 20:30
GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns(Businesswire)
2024-10-03 16:05
GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024(Business Wire)
2024-10-03 04:05
GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024(Businesswire)
2024-09-27 04:05
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2024-08-20 06:22
Daily – Vickers Top Buyers & Sellers for 08/20/2024(Argus Research)
2024-08-12 16:05
GeneDx to Participate in Fall Investor Conferences(Business Wire)
2024-08-12 04:05
GeneDx to Participate in Fall Investor Conferences(Businesswire)
2024-08-09 16:05
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2024-08-09 07:17
Daily – Vickers Top Buyers & Sellers for 08/09/2024(Argus Research)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.